<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-66875</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:description xml:lang="en">Clinical case: A 38-year-old man with fungalAlternaria keratitis was referred from another hospital25 days after post-traumatic penetrating keratoplastiasurgery on his right eye. We commencedtreatment with topical voriconazole and the conditionresolved.Discussion: Fungal Alternaria keratitis is rare, andtreatment is difficult because the clinical responsedoes not correlate well with the antibiotic in vitrosensitivity of the fungus. Clinical cases need to bediagnosed and treated quickly if visual loss is to beavoided. The combination of topical and systemicvoriconazole has been shown to be an effective treatmentfor this condition (AU)</dc:description>
<dc:creator>Barcia, M</dc:creator>
<dc:creator>Romero-Jung, P</dc:creator>
<dc:creator>Rodríguez-Ares, T</dc:creator>
<dc:creator>Touriño-Peralba, R</dc:creator>
<dc:creator>Pardo-Sánchez, F</dc:creator>
<dc:creator>Domingo-Barón, B de</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Caso clínico: Hombre de 38 años remitido de otrocentro por presentar queratitis fúngica por Alternaria25 días después de realizarle una queratoplastiapenetrante postraumática en ojo derecho. Se instauratratamiento con voriconazol tópico y oral conbuena evolución posterior.Discusión: Las queratitis fúngicas por Alternariason poco frecuentes. Su tratamiento es difícil porquela evolución clínica no se correlaciona con lasusceptibilidad in vitro del hongo. Producen cuadrosclínicos que requieren un rápido diagnóstico ytratamiento, para evitar la pérdida de visión. Lacombinación de voriconazol tópico y sistémicopuede ser una buena alternativa en caso de hongosresistentes al tratamiento convencional (AU)</dc:description>
<dc:source>Arch Soc Esp Oftalmol;83(8): 493-496, ago. 2008. ilus</dc:source>
<dc:identifier>ibc-66875</dc:identifier>
<dc:subject>^d29474^s22066</dc:subject>
<dc:subject>^d529^s22001</dc:subject>
<dc:subject>^d29474^s22053</dc:subject>
<dc:subject>^d29474^s22074</dc:subject>
<dc:subject>^d529^s22052</dc:subject>
<dc:subject>^d529^s22031</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d29474^s22045</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d7803^s22016</dc:subject>
<dc:subject>^d29431^s22045</dc:subject>
<dc:subject>^d7803^s22067</dc:subject>
<dc:subject>^d5153^s22053</dc:subject>
<dc:type>article</dc:type>
<dc:date>200808</dc:date>
</metadata>
</record>
</ibecs-document>
